Skip navigation

Establish Robust Processes to Support Financial Models, Accurate Forecasts and Portfolio Planning

November 17-19, 2016
  • Philadelphia, PA

Now in its 2nd year, CBI’s R&D and Clinical Financial Planning and Analysis Summit remains your go-to life sciences event to develop the robust processes needed to effectively support and implement financial models, accurate forecasts and portfolio planning within your organization. From manufacturing to clinical development, it is critical to set your organization up for financial success by building models that effectively track and analyze financial data throughout the clinical and
R&D lifecycle. Join us in November to benchmark against leading
industry experts and walk away with actionable financial strategies!

CPE
Credits *pending approval

Distinguished
Conference
Chairman:

Joseph Pocrass
Director, R&D Finance, Oncology Portfolio
MedImmune

Enhance Financial Control Policies for Increased and Accurate Data Capture:

  • Determine value measurements for early vs. late stage projects to enable successful portfolio management
  • Maximize the use of scenario-based planning for proactive vs. reactive financial planning
  • Learn to overcome the rising complexities in building and implementing an adaptive clinical trial financial model
  • Incorporate manufacturing information to ensure financial progress through clinical development
  • Examine how strong data visualization capabilities can improve overall communication and decision support within internal and external financial teams
  • Identify best practices for long-term cash flow management planning

PLUS! A Pre-Conference Workshop:

Advanced Strategies for Clinical Forecasting and
Expense Accrual Models

Previous Attendee Acclaim:

The open dialogues in the panel discussion were great!

Senior Financial Analyst, Vertex Pharmaceuticals

Great place to share common challenges and solutions.

Program Manager, Merrimack Pharmaceuticals

Great to touch on industry-wide issues. Everyone is working through the same issues at other companies.

Associate Director, Vertex Pharmaceuticals

November 17-18, 2016 DoubleTree by Hilton Philadelphia, PA

R&D and Clinical Financial Planning and Analysis Summit

Establish Robust Processes to Support Financial Models, Accurate Forecasts and Portfolio Planning

Now in its 2nd year, CBI’s R&D and Clinical Financial Planning and Analysis Summit remains your go-to life sciences event to develop the robust processes needed to effectively support and implement financial models, accurate forecasts and portfolio planning within your organization. From manufacturing to clinical development, it is critical to set your organization up for financial success by building models that effectively track and analyze financial data throughout the clinical and
R&D lifecycle. Join us in November to benchmark against leading
industry experts and walk away with actionable financial strategies!

CPE
Credits *pending approval

Distinguished
Conference
Chairman:

Joseph Pocrass
Director, R&D Finance, Oncology Portfolio
MedImmune

Enhance Financial Control Policies for Increased and Accurate Data Capture:

  • Determine value measurements for early vs. late stage projects to enable successful portfolio management
  • Maximize the use of scenario-based planning for proactive vs. reactive financial planning
  • Learn to overcome the rising complexities in building and implementing an adaptive clinical trial financial model
  • Incorporate manufacturing information to ensure financial progress through clinical development
  • Examine how strong data visualization capabilities can improve overall communication and decision support within internal and external financial teams
  • Identify best practices for long-term cash flow management planning

PLUS! A Pre-Conference Workshop:

Advanced Strategies for Clinical Forecasting and
Expense Accrual Models

Previous Attendee Acclaim:

The open dialogues in the panel discussion were great!

Senior Financial Analyst, Vertex Pharmaceuticals

Great place to share common challenges and solutions.

Program Manager, Merrimack Pharmaceuticals

Great to touch on industry-wide issues. Everyone is working through the same issues at other companies.

Associate Director, Vertex Pharmaceuticals

November 17-18, 2016 DoubleTree by Hilton Philadelphia, PA